33 results
DEFM14A
ELYM
Eliem Therapeutics Inc
4 Jun 24
Proxy related to merger
8:00am
Eliem’s near and long-term operating and strategic priorities. Among other things, these reviews and discussions focus on the opportunities and risks … associated with Eliem’s development programs, financial condition and potential long-term strategic options.
In the fall of 2022, the Eliem Board
PREM14A
ELYM
Eliem Therapeutics Inc
17 May 24
Preliminary proxy related to merger
4:36pm
and discuss Eliem’s near and long-term operating and strategic priorities. Among other things, these reviews and discussions focus on the opportunities … and risks associated with Eliem’s development programs, financial condition and potential long-term strategic options.
In the fall of 2022, the Eliem
DEFA14A
ELYM
Eliem Therapeutics Inc
11 Apr 24
Additional proxy soliciting materials
8:10am
, in order to advance the long-term business interests of Parent and the Company;
WHEREAS, Parent, Transitory Subsidiary and the Company intend
8-K
EX-2.1
ELYM
Eliem Therapeutics Inc
11 Apr 24
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
8:01am
the Company, in accordance with and on the terms contemplated by this Agreement, in order to advance the long-term business interests of Parent
8-K
EX-99.2
pbfuwfitf1a
14 Nov 22
Eliem Therapeutics Reports Third Quarter Financial and Business Highlights
6:10am
8-K
EX-99.1
d3wxbrzu8v3jfade4
14 Nov 22
Eliem Therapeutics Reports Third Quarter Financial and Business Highlights
6:10am
8-K
EX-99.1
lhayprfkvjxce6b5zdj6
5 Oct 22
Eliem Therapeutics Provides Update on Pipeline Progress
7:47am
8-K
EX-99.1
wm086
15 Aug 22
Eliem Therapeutics Reports Second Quarter Financial and Business Highlights
6:15am
8-K
qh0f5bojfg7ij1b
18 Jul 22
Other Events
5:21pm
8-K
EX-99.1
unr65b0fb jmyxth3
16 May 22
Eliem Therapeutics Reports First Quarter Financial and Business Highlights
6:24am
8-K
EX-99.1
nawsrkrq
7 Mar 22
Eliem Therapeutics Reports Fourth Quarter and Year-End Financial and Business Highlights
4:11pm
10-K
qwjiymle19 kk5
7 Mar 22
Annual report
4:03pm